EU medtech industry highlights areas of concern in RoHS revision proposals
This article was originally published in RAJ Devices
Three European medtech industry associations have identified several issues that they say need to be addressed regarding plans by the European Commission to include medical devices under the scope of the European directive on the restriction of hazardous substances in electrical and electronic equipment1,2.
You may also be interested in...
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.